跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Izbrid
Approved
STANDARD
Izbrid
Interphil Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3210218b53a69887
Company
Interphil Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
3210218b53a69887
Drug Approval Philippines Name
Izbrid
Product Name
Izbrid
Registration Number
DR-XY47981
Brand Name
Izbrid
Generic Name
Salbutamol (as sulfate) + Guaifenesin
Dosage Form
Syrup (Orange Flavor)
Dosage Strength
1mg/ 50mg
Manufacturer
Interphil Laboratories, Inc.
Trader
Xeno Pharmaceuticals Phils. Inc.
Issuance Date
29 April 2022
Expiry Date
29 April 2027
Pharmacologic Category
Bronchodilator/ Expectorant
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3210218b53a69887
Type
Standard
Back to Philippines FDA Approvals
Izbrid - Philippines FDA Drug Approval Details